The etiology of preeclampsia: The role of the father

Journal of Reproductive Immunology

Volumn 89, Issue 2, 2011, Pages 126-132

  Dekker, Gus ^a   Robillard, Pierre Yves ^b   Roberts, Claire ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Department of Obstetrics Neonatology and Gynaecology   (France)

Author keywords

Paternal risk factors; Pre eclampsia

Indexed keywords

CYTOKINE; HLA ANTIGEN;

DISEASE ASSOCIATION; HEREDITY; HLA SYSTEM; HUMAN; PATERNITY; PREECLAMPSIA; PRIMIGRAVIDA; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SEXUALITY; SINGLE NUCLEOTIDE POLYMORPHISM; SPERM;

CYTOKINES; FEMALE; FETUS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HLA ANTIGENS; HUMANS; MALE; PLACENTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; SEMEN; SEMINAL PLASMA PROTEINS; TROPHOBLASTS;

EID: 79956126940     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2010.12.010     Document Type: Review

References (71)

1. Alderman B.W., Sperling R.S., Daling J.R. An epidemiological study of the immunogenetic aetiology of preeclampsia. Br. Med. J. (Clin. Res. Ed.) 1986, 292:372-374.
2. Andraweera P., Thompson S., Zhang V., Nowak R., Dekker G., Roberts C. Maternal, paternal and fetal single nucleotide polymorphisms in vascular endothelial growth factor family genes associate with pregnancy complications. Am. J. Obstet. Gynecol. 2010, 201:S13. (SMFM abstract 220).
3. Astin M., Scott J.R., Worley R.J. Preeclampsia/eclampsia: a fatal father factor. Lancet 1981, 5(2):533.
4. Baird J.N. Eclampsia in a lowland gorilla. Am. J. Obstet. Gynecol. 1981, 141:345-346.
5. Bezold G., Politch J.A., Kiviat N.B., Kuypers J.M., Wolff H., Anderson D.J. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil. Steril. 2007, 87:1087-1097.
6. Caughey A.B., Stotland N.E., Washington A.E., Escobar G.J. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet. Gynecol. 2005, 106:156-161.
7. Chen X.K., Wen S.W., Smith G., Leader A., Sutandar M., Yang Q., Walker M. Maternal age, paternal age and new-onset hypertension in late pregnancy. Hypertens. Pregnancy 2006, 25:217-227.
8. Clifton V.L. Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta 2010, 31:S33-S39.
9. Chu T.M., Nocera M.A., Flanders K.C., Kawinski E. Localization of seminal plasma transforming growth factor-beta1 on human spermatozoa: an immunocytochemical study. Fertil. Steril. 1996, 66:327-330.
10. Conde-Agudelo A., Villar J., Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am. J. Obstet. Gynecol. 2008, 198:7-22.
11. Cross J.C. The genetics of preeclampsia: a feto-placental or maternal problem?. Clin. Genet. 2003, 64:96-103.
12. de Galan-Roosen A.E., Kuijpers J.C., Rosendaal F.R., Steegers E.A., van Beers W.A., Ponjee G.A., Merkus H.M. Maternal and paternal thrombophilia: risk factors for perinatal mortality. Br. J. Obstet. Gynaecol. 2005, 112:306-311.
13. Dejucq N., Jégou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol. Mol. Biol. Rev. 2001, 65:208-231.
14. Dekker G., Robillard P.Y. The birth interval hypothesis - does it really indicate the end of the primipaternity hypothesis?. J. Reprod. Immunol. 2003, 59:245-251.
15. Dekker G.A., Robillard P.Y. Preeclampsia: a couple's disease with maternal and fetal manifestations. Curr. Pharm. Des. 2005, 11:699-710.
16. Dekker G., Robillard P.Y. Preeclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update. J. Reprod. Immunol. 2007, 76:8-16.
17. Dekker G.A., Sibai B.M. Etiology and pathogenesis of preeclampsia: current concepts. Am. J. Obstet. Gynecol. 1998, 179:1359-1375.
18. de Luca Brunori I., Battini L., Simonelli M., Brunori E., Valentino V., Curcio M., Mariotti M.L., Lapi S., Genazzani A.R. HLA-DR in couples associated with preeclampsia: background and updating by DNA sequencing. J. Reprod. Immunol. 2003, 59:235-243.
19. Esplin M.S., Fausett M.B., Fraser A., et al. Paternal and maternal components of the predisposition to preeclampsia. N. Engl. J. Med. 2001, 344:867-872.
20. Fisher S., Genbacev O., Maidji E., Pereira L. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J. Virol. 2000, 74:6808-6820.
21. Gibson C.S., MacLennan A.H., Janssen N.G., Kist W.J., Hague W.M., Haan E.A., Goldwater P.N., Priest K., Dekker G.A., South Australian Cerebral Palsy Research Group Associations between fetal inherited thrombophilia and adverse pregnancy outcomes. Am. J. Obstet. Gynecol. 2006, 194(947):e1-e10.
22. Gibson C.S., Goldwater P.N., MacLennan A.H., Haan E.A., Priest K., Dekker G.A. Fetal exposure to herpesviruses may be associated with pregnancy-induced hypertensive disorders and preterm birth in a Caucasian population. BJOG 2008, 115:492-500.
23. Gibson C.S., MacLennan A.H., Goldwater P.N., Haan E.A., Priest K., Dekker G.A. Mannose-binding lectin haplotypes may be associated with cerebral palsy only after perinatal viral exposure. Am. J. Obstet. Gynecol. 2008, 198(509.). e1-509.e8.
24. Gibson C.S., MacLennan A.H., Haan E.A., Priest K., Dekker G.A., Writing for the South Australian Cerebral Palsy Research Group Fetal MBL2 haplotypes combined with viral exposure are associated with adverse pregnancy outcomes. J. Matern. Fetal Neonatal Med. 2010, 10.3109/14767058.2010.531324.
25. Grob B., Knapp L.A., Martin R.D., Anzenberger G. The major histocompatibility complex and mate choice: inbreeding avoidance and selection of good genes. Exp. Clin. Immunogenet. 1998, 15:119-129.
26. Haig D. Genetic conflicts in human pregnancy. Q. Rev. Biol. 1993, 68:495-532.
27. Harlap S., Paltiel O., Deutsch L., Knaanie A., Masalha S., Tiram E., Caplan L.S., Malaspina D., Friedlander Y. Paternal age and preeclampsia. Epidemiology 2002, 13:660-667.
28. Hiby S.E., Walker J.J., O'Shaughnessy K.M., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 2004, 200:957-965.
29. Jarvis M.A., Nelson J.A. Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr. Opin. Microbiol. 2002, 5:403-407.
30. Kapranos N., Petrakou E., Anastasiadou C., Kotronias D. Detection of herpes simplex virus, cytomegalovirus, and Epstein-Barr virus in the semen of men attending an infertility clinic. Fertil. Steril. 2003, 79(Suppl. 3):1566-1570.
31. Kho E.M., McCowan L.M., North R.A., Roberts C.T., Chan E., Black M.A., Taylor R.S., Dekker G.A., SCOPE Consortium Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. J. Reprod. Immunol. 2009, 82:66-73.
32. Lachmeijer A.M., Arngrimsson R., Bastiaans E.J., Frigge M.L., Pals G., Sigurdardottir S., Stefansson H., Palsson B., Nicolae D., Kong A., Aarnoudse J.G., Gulcher J.R., Dekker G.A., ten Kate L.P., Stefansson K. A genome-wide scan for preeclampsia in the Netherlands. Eur. J. Hum. Genet. 2001, 9:758-764.
33. Larsen M.H., Hylenius S., Andersen A.M., Hviid T.V. The 3'-untranslated region of the HLA-G gene in relation to preeclampsia: revisited. Tissue Antigens 2010, 75:253-261.
34. Lash G.E., Schiessl B., Kirkley M., Innes B.A., Cooper A., Searle R.F., Robson S.C., Bulmer J.N. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J. Leukoc. Biol. 2006, 80:572-580.
35. Leonard S., Murrant C., Tayade C., van den Heuvel M., Watering R., Croy B.A. Mechanisms regulating immune cell contributions to spiral artery modification - facts and hypotheses - a review. Placenta 2006, 27 S:40-46.
36. Lie R.T., Rasmussen S., Brunborg H., Gjessing H.K., Lie-Nielsen E., Irgens L.M. Fetal and maternal contributions to risk of preeclampsia: a population based study. Br. Med. J. 1998, 316:1343-1347.
37. Madsen H.O., Garred P., Thiel S., Kurtzhals J.A., Lamm L.U., Ryder L.P., Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J. Immunol. 1995, 155:3013-3020.
38. Marti J.J., Herrmann U. Immunogestosis: a new etiologic concept of " essential" EPH gestosis, with special consideration of the primigravid patient: preliminary report of a clinical study. Am. J. Obstet. Gynecol. 1977, 128:489-493.
39. Matsushita M., Hijikata M., Ohta Y., Iwata K., Matsumoto M., Nakao K., Kanai K., Yoshida N., Baba K., Mishiro S. Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL. Arch. Virol 1998, 143:645-651.
40. McCowan L., North R., Kho E.M., Black M., Chan E., Dekker G., Poston L., Taylor R., Claire R. Paternal contribution to small for gestational age babies: a multicentre prospective study. Obesity (Silver Spring) 2010, 10.1038/oby.2010.279.
41. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2002, 2:656-663.
42. Mullighan C.G., Marshall S.E., Welsh K.I. Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand. J. Immunol. 2000, 51:111-122.
43. Ness R.B., Markovic N., Harger G., Day R. Barrier methods, length of preconception intercourse, and preeclampsia. Hypertens Pregnancy 2004, 23:227-235.
44. Nilsson E., Salonen Ros H., Cnattingius S., Lichtenstein P. The importance of genetic and environmental effects for preeclampsia and gestational hypertension: a family study. BJOG 2004, 111:200-206.
45. Nocera M., Chu T.M. Characterization of latent transforming growth factor-beta from human seminal plasma. Am. J. Reprod. Immunol. 1995, 33:282-291.
46. Olayemi O., Strobino D., Aimakhu C., Adedapo K., Kehinde A., Odukogbe A.T., Salako B. Influence of duration of sexual cohabitation on the risk of hypertension in nulliparous parturients in Ibadan: a cohort study. Aust. N. Z. J. Obstet. Gynaecol. 2010, 50:40-44.
47. Oudejans C.B., Mulders J., Lachmeijer A.M., Van Dijk M., Konst A.A., Westerman B.A., Van Wijk I.J., Leegwater P.A., Kato H.D., Matsuda T., Wake N., Dekker G.A., Pals G., Ten Kate L.P., Blankenstein M.A. The parent-of-origin effect of 10q22 in preeclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentas. Mol. Hum. Reprod. 2004, 10:589-598.
48. Ozdemir O., Dinleyici E.C., Tekin N., Colak O., Aksit M.A. Low-mannose-binding lectin levels in susceptibility to neonatal sepsis in preterm neonates with fetal inflammatory response syndrome. J. Matern. Fetal Neonatal Med. Early Online 2010, 1-5.
49. Peters B., Whittall T., Babaahmady K., Gray K., Vaughan R., Lehner T. Effect of heterosexual intercourse on mucosal alloimmunisation and resistance to HIV-1 infection. Lancet 2004, 363:518-524.
50. Petersen S.V., Thiel S., Jensen L., Vorup-Jensen T., Koch C., Jensenius J.C. Control of the classical and the MBL pathway of complement activation. Mol. Immunol. 2000, 37:803-811.
51. Redman C.W., Sargent I.L. Placental stress and preeclampsia: a revised view. Placenta 2009, 30:S38-42.
52. Rigó J., Boze T., Derzsy Z., Derzbach L., Treszl A., Lázár L., Sobel G., Vásárhelyi B. Family history of early-onset cardiovascular disorders is associated with a higher risk of severe preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2006, 128:148-151.
53. Roberts C.T. IFPA award in placentology lecture: complicated interactions between genes and the environment in placentation, pregnancy outcome and long term health. Placenta 2010, 31(Suppl.):S47-53.
54. Robertson S.A., Ingman W.V., O'Leary S., Sharkey D.J., Tremellen K.P. Transforming growth factor beta - a mediator of immune deviation in seminal plasma. J. Reprod. Immunol. 2002, 57:109-128.
55. Robertson S.A., Guerin L.R., Bromfield J.J., Branson K.M., Ahlström A.C., Care A.S. Seminal fluid drives expansion of the CD4+CD25+T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol. Reprod. 2009, 80:1036-1045.
56. Robillard P.Y., Hulsey T.C., Perianin J., Janky E., Miri E.H., Papiernik E. Association of pregnancy induced hypertension with duration of sexual cohabitation before conception. Lancet 1994, 344:973-975.
57. Robillard P.Y., Dekker G., Chaouat G., Hulsey T.C. Etiology of preeclampsia: maternal vascular predisposition and couple disease - mutual exclusion or complementarity?. J. Reprod. Immunol. 2007, 76:1-7.
58. Saito S., Takeda Y., Sakai M., Nakabayahi M., Hayakawa S. The incidence of preeclampsia among couples consisting of Japanese women and Caucasian men. J. Reprod. Immunol. 2006, 70:93-98.
59. Scott K. Sex and the MHC. Dev. Cell 2003, 4:290-291.
60. Sharkey D.J., Macpherson A.M., Tremellen K.P., Robertson S.A. Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. Mol. Hum. Reprod. 2007, 13:491-501.
61. Sibai B., Dekker G., Kupferminc M. Preeclampsia. Lancet 2005, 365:785-799.
62. Skjaerven R., Wilcox A.J., Lie R.T. The interval between pregnancies and the risk of preeclampsia. N. Engl. J. Med. 2002, 346:33-38.
63. Tan C.Y., Ho J.F., Chong Y.S., Loganath A., Chan Y.H., Ravichandran J., Lee C.G., Chong S.S. Paternal contribution of HLA-G*0106 significantly increases risk for preeclampsia in multigravid pregnancies. Mol. Hum. Reprod. 2008, 14:317-324.
64. Trogstad L.I., Eskild A., Bruu A.L., Jeansson S., Jenum P.A. Is preeclampsia an infectious disease?. Acta Obstet. Gynecol. Scand. 2001, 80:1036-1038.
65. Turner M.W., Hamvas R.M. Mannose-binding lectin: structure, function, genetics and disease associations. Rev. Immunogenet. 2000, 2:305-322.
66. Vatten L.J., Skjaerven R. Offspring sex and pregnancy outcome by length of gestation. Early Hum. Dev. 2004, 76:47-54.
67. Walpole N.G., Kjer-Nielsen L., Kostenko L., McCluskey J., Brooks A.G., Rossjohn J., Clements C.S. The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide. J. Mol. Biol. 2010, 397:467-480.
68. Wang J.X., Knottnerus A.M., Schuit G., Norman R.J., Chan A., Dekker G.A. Surgically obtained sperm, and risk of gestational hypertension and preeclampsia. Lancet 2002, 359:673-674.
69. Wedekind C., Füri S. Body odour preferences in men and women: do they aim for specific MHC combinations or simply heterozygosity?. Proc. Biol. Sci. 1997, 264:1471-1479.
70. Xie F., Hu Y., Magee L.A., Money D.M., Patrick D.M., Krajden M., Thomas E., von Dadelszen P. An association between cytomegalovirus infection and preeclampsia: a case-control study and data synthesis. Acta Obstet. Gynecol. Scand. 2010, 89:1162-1167.
71. Zusterzeel P.L., te Morsche R., Raijmakers M.T., Roes E.M., Peters W.H., Steegers E.A. Paternal contribution to the risk for preeclampsia. J. Med. Genet. 2002, 39:44-45.